137 related articles for article (PubMed ID: 31605415)
1. The significance of PA28γ and U2AF1 in oral mucosal carcinogenesis.
Yin F; Wang J; Zhao K; Xin C; Shi Y; Zeng X; Xu H; Li J; Chen Q
Oral Dis; 2020 Jan; 26(1):53-61. PubMed ID: 31605415
[TBL] [Abstract][Full Text] [Related]
2. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Li J; Feng X; Sun C; Zeng X; Xie L; Xu H; Li T; Wang R; Xu X; Zhou X; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Jiang L; Wang Z; Chen Q
EBioMedicine; 2015 Aug; 2(8):851-8. PubMed ID: 26425691
[TBL] [Abstract][Full Text] [Related]
3. A novel transcript variant of proteasome activator 28γ: Identification and function in oral cancer cells.
Xu X; Liu D; Ji N; Li T; Li L; Jiang L; Li J; Zhang P; Zeng X; Chen Q
Int J Oncol; 2015 Jul; 47(1):188-94. PubMed ID: 25936920
[TBL] [Abstract][Full Text] [Related]
4. [Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression].
Xin C; Wang JK; Li J; Zeng X
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Feb; 38(1):6-10. PubMed ID: 32037759
[TBL] [Abstract][Full Text] [Related]
5. PA28γ acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma.
Liu S; Liu D; Zeng X; Wang J; Liu J; Cheng J; Lei K; Bai H; Ji N; Zhou M; Jiang L; Dan H; Li J; Chen Q
Cancer Lett; 2018 Aug; 428():192-200. PubMed ID: 29702196
[TBL] [Abstract][Full Text] [Related]
6. Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.
Xie C; Li Z; Hua Y; Sun S; Zhong L; Chen Q; Feng H; Ji N; Li T; Zhou X; Zeng X; Tang Z; Sun C; Li J; Chen Q
Cell Death Dis; 2022 Aug; 13(8):701. PubMed ID: 35961969
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of CD44 and CD133 expression in oral potentially malignant disorder and oral squamous cell carcinoma].
Jiajia Q; Yan S; Changqing Y; Wenjing J; Han Z; Yuanpan C; Qiuyan L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):311-316. PubMed ID: 28675018
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein activates proteasomal activator 28 gamma expression via upregulation of p53 levels to stimulate virus replication.
Yeom S; Jeong H; Kim SS; Jang KL
J Gen Virol; 2018 May; 99(5):655-666. PubMed ID: 29611800
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.
Jeon J; Kim W; Jang J; Isacson O; Seo H
Neuroscience; 2016 Jun; 324():20-8. PubMed ID: 26944602
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.
Tripathi LP; Kambara H; Moriishi K; Morita E; Abe T; Mori Y; Chen YA; Matsuura Y; Mizuguchi K
J Proteome Res; 2012 Jul; 11(7):3664-79. PubMed ID: 22646850
[TBL] [Abstract][Full Text] [Related]
11. PA28γ: New Insights on an Ancient Proteasome Activator.
Cascio P
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562807
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.
Lin SC; Liu CJ; Ji SH; Hung WW; Liu YC; Chang SR; Tu HF; Chang KW
Clin Oral Investig; 2022 Feb; 26(2):1343-1351. PubMed ID: 34342761
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of spliceosome U2AF1 significantly inhibits the development of human erythroid cells.
Zhang J; Zhao H; Wu K; Peng Y; Han X; Zhang H; Liang L; Chen H; Hu J; Qu X; Zhang S; Chen L; Liu J
J Cell Mol Med; 2019 Aug; 23(8):5076-5086. PubMed ID: 31144421
[TBL] [Abstract][Full Text] [Related]
14. Decreased cytoplasmic X-box binding protein-1 expression is associated with poor prognosis and overall survival in patients with oral squamous cell carcinoma.
Hsu HT; Hsing MT; Yeh CM; Chen CJ; Yang JS; Yeh KT
Clin Chim Acta; 2018 Apr; 479():66-71. PubMed ID: 29305191
[TBL] [Abstract][Full Text] [Related]
15. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).
Nian Q; Li Y; Li J; Zhao L; Rodrigues Lima F; Zeng J; Liu R; Ye Z
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975232
[TBL] [Abstract][Full Text] [Related]
16. Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity.
Moncsek A; Gruner M; Meyer H; Lehmann A; Kloetzel PM; Stohwasser R
Apoptosis; 2015 Sep; 20(9):1211-28. PubMed ID: 26201457
[TBL] [Abstract][Full Text] [Related]
17. Proteasome activator PA28γ stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA.
Kanai K; Aramata S; Katakami S; Yasuda K; Kataoka K
J Mol Endocrinol; 2011 Aug; 47(1):119-127. PubMed ID: 21830322
[TBL] [Abstract][Full Text] [Related]
18. The proteasome activator PA28γ, a negative regulator of p53, is transcriptionally up-regulated by p53.
Wan ZX; Yuan DM; Zhuo YM; Yi X; Zhou J; Xu ZX; Zhou JL
Int J Mol Sci; 2014 Feb; 15(2):2573-84. PubMed ID: 24531141
[TBL] [Abstract][Full Text] [Related]
19. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
[TBL] [Abstract][Full Text] [Related]
20. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
